Synkrino Biotherapeutics vs Seismic Therapeutic
Side-by-side comparison of AI visibility scores, market position, and capabilities
Synkrino Biotherapeutics uses its AI and Immunology Discovery Engine (AIDE) to identify novel drug targets from immune patient tissue data; targets immune-mediated and inflammatory diseases; early-stage Oakland, CA biotech.
About
Synkrino Biotherapeutics is an Oakland, California-based biotechnology company applying artificial intelligence and multiomics analysis to drug discovery in immune-mediated and inflammatory diseases. Its core proprietary platform, the AI and Immunology Discovery Engine (AIDE), integrates high-dimensional immune tissue data from patients — including single-cell RNA sequencing, spatial transcriptomics, and proteomics — with machine learning models to identify novel, biologically validated drug targets that emerge from the real immunological complexity of human disease rather than simplified preclinical models.
Seismic Therapeutic raised $222M+ total ($121M Series B in 2023, $25M in 2025) using its IMPACT ML platform; dosed first patient in Phase 1 for S-4321 bifunctional antibody in autoimmune disease.
About
Seismic Therapeutic is a clinical-stage biotechnology company based in Boston, Massachusetts that applies machine learning to the discovery and development of novel immunotherapies for autoimmune diseases. Founded with a focus on precision immunology, Seismic built its IMPACT platform to model the complex biology of adaptive immunity — identifying which immune cell populations drive specific autoimmune conditions and designing biologics that precisely modulate those populations without broadly suppressing the immune system. This targeted approach aims to produce safer, more effective treatments for conditions like lupus, rheumatoid arthritis, and inflammatory bowel disease.
AI Visibility Head-to-Head
Key Details
Also Compare
Synkrino Biotherapeutics vs
Seismic Therapeutic vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.